BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2019
View Archived Issues
Acetyl CoA and metabolic health
Read More
Synthesis and in vitro characterization of new analogues of manogepix against Cryptococcus spp.
Read More
New prostate cancer treatment strategy may overcome resistance
Read More
Durvalumab does not improve efficacy of azacitidine in phase II AML/MDS trial
Read More
AST-008 demonstrates activity in patients with MCC
Read More
CBDVHS demonstrates enhanced antiseizure activity compared to CBD
Read More
Lilly initiates phase III LIBRETTO-431 study of selpercatinib
Read More
VRG-50014 rescues ALS phenotypes in preclinical models
Read More
NCKAP1 as a new therapeutic target in ALS
Read More
CYT-0853 demonstrates promising activity in models of autoimmune disease
Read More
Discovery and preclinical characterization of novel DHODH inhibitors for AML
Read More
Novel FVIII mimetic bispecific antibody Mim8 exhibits preclinical efficacy against hemophilia A
Read More
Positive early phase I data for Genmab's CD3xCD20 bispecific antibody GEN-3013
Read More
Transgene and BioInvent report preclinical data on BT-001 for solid tumors
Read More
BAR Pharmaceuticals describes new NR1H4 antagonists
Read More
Beijing Scitech-Mq Pharmaceuticals patents EGFR and/or ALK inhibitors
Read More
3M Pharmaceuticals presents cytokine-releasing compounds for infections
Read More
Roche and Genentech identify SCN9A blockers
Read More
Helix begins phase Ib/II study of L-DOS47 in previously treated pancreatic cancer
Read More
Canadian researchers synthesize new androgen receptor antagonists
Read More
Xintela's function-blocking antibody suppresses growth of glioblastoma tumors in preclinical model
Read More
Transgene opens enrollment in phase I study of TG-4050 for ovarian cancer
Read More
Emergex advances early development of vaccine candidate against F. tularensis
Read More